NEW YORK, March 7 - Oxford GlycoSciences on Thursday said that CEO Michael Kranda will step down by the end of this year.

The company said Kranda, who has been at OGS for six years, cited "personal family reasons" for his decision to leave. Chairman G. Kirk Raab said the company has begun looking for a replacement.

 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.